MetaCap

AnaptysBio (ANAB) vs Kailera Therapeutics (KLRA)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Kailera Therapeutics is the larger company by market cap ($1.43 billion vs $1.39 billion), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ANAB+3.61%KLRA-57.62%
+61%-3%-67%
Apr 17, 20261 yearNov 20, 2026
ANAB+3.61%KLRA-57.62%
+60%-3%-66%
Apr 13, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ANAB versus KLRA key metrics
MetricANABKLRA
Share price$46.63$11.02
Market cap$1.39B$1.43B
1-day change-1.62%-4.84%
YTD return+44.28%—
1-year return+76.58%—
5-year return+124.76%—
P/E ratio (TTM)7.15—
Forward P/E8.66—
EPS (TTM)$6.52$-4.16
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$234.60M—
Revenue growth (YoY)+157.01%—
Net income (latest FY)$-13.23M—
Operating margin96.72%—
Net margin-5.64%—
52-week high$72.36$28.23
52-week low$26.01$9.76
Distance from 52-week high-35.56%-60.96%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+87.11%+290.20%
Average volume496.92K1.08M
Shares outstanding29.73M129.85M
Employees—145
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About AnaptysBio

ANAB stock →

AnaptysBio, Inc. discovers and out-licenses therapeutic bodies in the United States.

Health Care · Biotechnology: Pharmaceutical Preparations

About Kailera Therapeutics

KLRA stock →

Kailera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company developing therapies for obesity and related conditions.

Health Care · Biotechnology: Pharmaceutical Preparations · 145 employees

ANAB vs KLRA FAQ

Which is bigger, AnaptysBio or Kailera Therapeutics?

Kailera Therapeutics (KLRA) is larger, with a market capitalization of $1.43B compared with $1.39B for AnaptysBio (ANAB).

Are AnaptysBio and Kailera Therapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons